Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
IDEXX Laboratories
(NASDAQ:IDXX)
Intraday
$479.57
3.22
[0.68%]
After-Hours
$479.57
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$479.57
3.22
[0.68%]
At close: Apr 22
$479.57
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Q1 2024 Earnings in 8 days from now on Wed May 1st, before the market open
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for IDEXX Laboratories Stock (NASDAQ:IDXX)
IDEXX Laboratories Stock (NASDAQ: IDXX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 16, 2024
$1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth This Much Today
Benzinga Insights
-
6 days ago
Monday, April 01, 2024
Investor Activism: Elanco Animal Health Settles with Ancora, Adds New Board Members
Vandana Singh
-
Apr 1, 2024, 8:45AM
Wednesday, March 27, 2024
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years
Benzinga Insights
-
Mar 27, 2024, 2:30PM
Monday, March 11, 2024
$100 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
-
Mar 11, 2024, 1:00PM
Tuesday, February 27, 2024
Here's How Much $1000 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today
Benzinga Insights
-
Feb 27, 2024, 3:00PM
Monday, February 19, 2024
Peering Into IDEXX Laboratories's Recent Short Interest
Benzinga Insights
-
Feb 19, 2024, 10:30AM
Thursday, February 08, 2024
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 15 Years
Benzinga Insights
-
Feb 8, 2024, 4:30PM
Tuesday, February 06, 2024
Where IDEXX Laboratories Stands With Analysts
Benzinga Insights
-
Feb 6, 2024, 2:00PM
JP Morgan Maintains Overweight on IDEXX Laboratories, Raises Price Target to $630
Benzinga Newsdesk
-
Feb 6, 2024, 1:59PM
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $655
Benzinga Newsdesk
-
Feb 6, 2024, 10:45AM
Monday, February 05, 2024
Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?
Piero Cingari
-
Feb 5, 2024, 2:12PM
Why Is Animal Diagnostic-Focused IDEXX Laboratories Stock Trading Higher Today?
Vandana Singh
-
Feb 5, 2024, 1:20PM
A Closer Look at IDEXX Laboratories's Options Market Dynamics
Benzinga Insights
-
Feb 5, 2024, 12:45PM
IDEXX Laboratories shares are trading higher after the company reported better-than-expected Q4 results.
Benzinga Newsdesk
-
Feb 5, 2024, 10:26AM
IDEXX Laboratories Forecasts FY24 EPS Of $10.84-$11.33 Versus Consensus Of $11.00, Reflecting Reported And Organic Growth Of 8%-13%
Benzinga Newsdesk
-
Feb 5, 2024, 6:38AM
IDEXX Laboratories Forecasts FY24 Sales Of $3.93B-$4.04B Versus Consensus Of $3.97B, Reflecting Full Year Growth Of 7.5%-10.5% As Reported And 7%-10% On An Organic Basis
Benzinga Newsdesk
-
Feb 5, 2024, 6:36AM
IDEXX Laboratories Q4 Adjusted PS $2.34 Beats $2.12 Estimate, Sales $901.60M Beat $891.25M Estimate
Benzinga Newsdesk
-
Feb 5, 2024, 6:32AM
Earnings Scheduled For February 5, 2024
Benzinga Insights
-
Feb 5, 2024, 5:20AM
Friday, February 02, 2024
IDEXX Laboratories Earnings Preview
Benzinga Insights
-
Feb 2, 2024, 11:01AM
Tuesday, January 30, 2024
Piper Sandler Downgrades IDEXX Laboratories to Neutral, Announces $525 Price Target
Benzinga Newsdesk
-
Jan 30, 2024, 5:36AM
Wednesday, January 17, 2024
Beyond The Numbers: 6 Analysts Discuss IDEXX Laboratories Stock
Benzinga Insights
-
Jan 17, 2024, 11:00AM
Goldman Sachs Maintains Buy on IDEXX Laboratories, Raises Price Target to $650
Benzinga Newsdesk
-
Jan 17, 2024, 10:18AM
Tuesday, January 16, 2024
P/E Ratio Insights for IDEXX Laboratories
Benzinga Insights
-
Jan 16, 2024, 10:15AM
Friday, January 12, 2024
(IDXX) - Analyzing IDEXX Laboratories's Short Interest
Benzinga Insights
-
Jan 12, 2024, 10:00AM
IDEXX Laboratories Says It Expanded Fecal Dx Antigen Testing Platform With Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years
Benzinga Newsdesk
-
Jan 12, 2024, 7:07AM
Monday, January 08, 2024
$1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth This Much Today
Benzinga Insights
-
Jan 8, 2024, 12:30PM
Tuesday, December 19, 2023
If You Invested $100 In This Stock 10 Years Ago, You Would Have $1,000 Today
Benzinga Insights
-
Dec 19, 2023, 11:30AM
Wednesday, December 13, 2023
(IDXX) - Analyzing IDEXX Laboratories's Short Interest
Benzinga Insights
-
Dec 13, 2023, 3:15PM
Thursday, December 07, 2023
$1000 Invested In This Stock 10 Years Ago Would Be Worth $10,000 Today
Benzinga Insights
-
Dec 7, 2023, 4:00PM
Insider Decision: Jonathan Jay Mazelsky Exercises Options At IDEXX Laboratories For $5.93M
Benzinga Insights
-
Dec 7, 2023, 10:02AM
Monday, December 04, 2023
SAIC Reports Q3 Results, Joins Uber, Wallbox And Other Big Stocks Moving Higher On Monday
Lisa Levin
-
Dec 4, 2023, 10:33AM
Monday, November 20, 2023
Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today
Benzinga Insights
-
Nov 20, 2023, 10:00AM
Thursday, November 09, 2023
IDEXX Laboratories Executive Vice President Acquires 1,728 Shares After Exercising Company Stock Options
Benzinga Insights
-
Nov 9, 2023, 10:01AM
Tuesday, November 07, 2023
Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today
Benzinga Insights
-
Nov 7, 2023, 10:00AM
Monday, November 06, 2023
How Is The Market Feeling About IDEXX Laboratories?
Benzinga Insights
-
Nov 6, 2023, 12:15PM
Piper Sandler Maintains Overweight on IDEXX Laboratories, Raises Price Target to $525
Benzinga Newsdesk
-
Nov 6, 2023, 10:19AM
Friday, November 03, 2023
Shares of healthcare equipment and healthcare provider stocks are trading higher amid overall market strength. Strength may also be attributed to Cardinal Health after the company reported better-than-expected Q1 financial results.
Benzinga Newsdesk
-
Nov 3, 2023, 3:33PM
5 Analysts Have This to Say About IDEXX Laboratories
Benzinga Insights
-
Nov 3, 2023, 11:00AM
Goldman Sachs Maintains Buy on IDEXX Laboratories, Lowers Price Target to $500
Benzinga Newsdesk
-
Nov 3, 2023, 10:42AM
Thursday, November 02, 2023
JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $550
Benzinga Newsdesk
-
Nov 2, 2023, 5:44PM
IDEXX Laboratories shares are trading higher after Barclays maintained an Overweight rating on the stock and raised its price target from $590 to $592.
Benzinga Newsdesk
-
Nov 2, 2023, 12:07PM
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $592
Benzinga Newsdesk
-
Nov 2, 2023, 11:21AM
Wednesday, November 01, 2023
Is There An Opportunity To Buy IDEXX Labs, The Animal Diagnostics-Focused Firm Stock After Q3 Performance? Analyst Answers
Vandana Singh
-
Nov 1, 2023, 12:32PM
IDEXX Laboratories shares are trading lower after the company reported a Q3 revenue miss and lowered its FY23 revenue guidance.
Benzinga Newsdesk
-
Nov 1, 2023, 11:18AM
Earnings Scheduled For November 1, 2023
Benzinga Insights
-
Nov 1, 2023, 7:19AM
IDEXX Laboratories Raises FY2023 EPS Guidance from $9.64-$9.90 to $9.74-$9.90 vs $9.82 Est; Lowers FY2023 Sales Guidance from $3.66B-$3.71B to $3.64B-$3.65B vs $3.68B Est
Benzinga Newsdesk
-
Nov 1, 2023, 6:38AM
IDEXX Laboratories Q3 Adj. EPS $2.50 Beats $2.37 Estimate, Sales $915.53M Miss $926.76M Estimate
Benzinga Newsdesk
-
Nov 1, 2023, 6:35AM
Tuesday, October 31, 2023
IDEXX Laboratories's Earnings: A Preview
Benzinga Insights
-
Oct 31, 2023, 3:01PM
Monday, October 30, 2023
This Is What Whales Are Betting On IDEXX Laboratories
Benzinga Insights
-
Oct 30, 2023, 1:45PM
Stifel Maintains Hold on IDEXX Laboratories, Lowers Price Target to $460
Benzinga Newsdesk
-
Oct 30, 2023, 11:10AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch